Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 202,463 | 191,142 | 177,890 | 154,247 | 170,112 |
| Marketable Securities | N/A | N/A | N/A | 24,605 | N/A |
| Receivables | 39,297 | 42,365 | 45,489 | 44,021 | 40,068 |
| Inventories | 15,887 | 11,572 | 13,306 | 14,294 | 13,798 |
| TOTAL | $271,163 | $259,480 | $251,503 | $248,636 | $238,516 |
| Non-Current Assets | |||||
| PPE Net | 19,288 | 18,510 | 18,072 | 17,702 | 17,237 |
| Intangibles | 816,743 | 863,664 | 869,944 | 870,757 | 853,427 |
| Other Non-Current Assets | 17,749 | 19,460 | 17,600 | 19,327 | 16,777 |
| TOTAL | $853,780 | $901,634 | $905,616 | $907,786 | $887,441 |
| Total Assets | $1,124,943 | $1,161,114 | $1,157,119 | $1,156,422 | $1,125,957 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 1,187 |
| Accounts payable and accrued liabilities | 12,531 | 12,895 | 15,655 | 11,911 | 11,114 |
| Accrued Expenses | 34,828 | 34,427 | 30,641 | 37,774 | 32,137 |
| Other current liabilities | 2,680 | 3,478 | 3,427 | 6,246 | 6,093 |
| TOTAL | $57,260 | $58,151 | $55,993 | $62,614 | $58,352 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,214 | 2,378 | 2,194 | 2,613 | 3,863 |
| Other Non-Current Liabilities | 9,980 | 15,538 | 15,273 | 14,077 | 15,086 |
| TOTAL | $13,624 | $20,245 | $19,867 | $18,608 | $19,428 |
| Total Liabilities | $70,884 | $78,396 | $75,860 | $81,222 | $77,780 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,040 | 72,751 | 72,417 | 72,150 | 71,753 |
| Common Shares | 73 | 73 | 72 | 72 | 72 |
| Retained earnings | -34,197 | -410,210 | -401,808 | -393,717 | -389,873 |
| Other shareholders' equity | -439,828 | -27,783 | -26,866 | -31,346 | -54,066 |
| TOTAL | $1,054,059 | $1,082,718 | $1,081,259 | $1,075,200 | $1,048,177 |
| Total Liabilities And Equity | $1,124,943 | $1,161,114 | $1,157,119 | $1,156,422 | $1,125,957 |